Yet, I assess that Viking Therapeutics’s main growth vector will likely be imputed to its ability to commercialize and monetize its obesity pipeline. With Pfizer (PFE) suffering a notable setback, we ...

His background includes key positions at CordenPharma, AmbioPharma, and CoreRx, where he successfully led sales and business development efforts. Lifecore plans to grant him stock options as part ...

Detailed price information for Lifecore Biomedical Inc (LFCR-Q) from The Globe and Mail including charting and trades.

Company Logo Dublin, May 20, 2025 (GLOBE NEWSWIRE) -- The "U.S. Small Molecule Innovator API CDMO Market Size, Share & Trends Analysis Report by Stage Type (Preclinical, Clinical, Commercial ...